Kevie Feit

Randomized Phase III Study of Exatecan and Gemcitabine Compared With Gemcitabine Alone in Untreated Advanced Pancreatic Cancer

Ghassan K. Abou‐Alfa, Richard Létourneau, Graydon Harker et al. · Journal of Clinical Oncology · 2006 · 278 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy

Johann S. de Bono, L. Rhoda Molife, Guru Sonpavde et al. · Annals of Oncology · 2011 · 60 citations · Full text

Medicine, Oncology, Urology +16

A phase 2 study of TZT-1027, administered weekly to patients with advanced non-small cell lung cancer following treatment with platinum-based chemotherapy

Gregory J. Riely, Shirish M. Gadgeel, Ivan Rothman et al. · Lung Cancer · 2006 · 58 citations

Medicine, Oncology, Pharmacotherapy +12

Phase II study of intravenous TZT‐1027 in patients with advanced or metastatic soft‐tissue sarcomas with prior exposure to anthracycline‐based chemotherapy

Shreyaskumar Patel, Mary Louise Keohan, Muhammad Wasif Saif et al. · Cancer · 2006 · 57 citations · Full text

Medicine, Oncology, Pharmacology +11

Phase 2 study of lenvatinib (LN) in patients (Pts) with RET fusion-positive adenocarcinoma of the lung

Vamsidhar Velcheti, Toyoaki Hida, Karen L. Reckamp et al. · Annals of Oncology · 2016 · 40 citations · Full text

Medicine, Oncology, Surgery +14